Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Monday 01 June, 2020

GlaxoSmithKline PLC

Total Voting Rights

RNS Number : 5569O
GlaxoSmithKline PLC
01 June 2020
 

 

GlaxoSmithKline plc

 

Total Voting Rights and Capital

 

In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the 'Company') hereby notifies the market of the following:

 

The Company's issued share capital as at 31 May 2020 consisted of 5,384,879,604 shares of 25 pence each ('Ordinary Shares'), of which 367,705,950 Ordinary Shares were held in Treasury.

 

Therefore, the total number of voting rights in the Company is 5,017,173,654. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

 

 

 

V A Whyte

Company Secretary

 

1 June 2020

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
TVRUPUUGQUPUGGG

a d v e r t i s e m e n t